63 related articles for article (PubMed ID: 9196440)
1. An immunocytochemical study of MHC class I expression on human Langerhans cells and melanocytes.
Moseley RP; Brown JI; Auld J; Mumtaz H; Rainey AJ; Kirkham N; Gelsthorpe K; Masters R; Smith ME
J Pathol; 1997 Apr; 181(4):419-25. PubMed ID: 9196440
[TBL] [Abstract][Full Text] [Related]
2. Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells.
MacAry PA; Lindsay M; Scott MA; Craig JI; Luzio JP; Lehner PJ
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3982-7. PubMed ID: 11274420
[TBL] [Abstract][Full Text] [Related]
3. Quantitative differences in cell surface expression of class I MHC antigens on murine epidermal Langerhans cells.
Sharrow SO; Barden LA; Singer A; Katz SI
J Immunol; 1994 Jul; 153(1):110-6. PubMed ID: 8207229
[TBL] [Abstract][Full Text] [Related]
4. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells.
Hamrah P; Zhang Q; Liu Y; Dana MR
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):639-46. PubMed ID: 11867578
[TBL] [Abstract][Full Text] [Related]
5. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
Andratschke M; Pauli C; Stein M; Chaubal S; Wollenberg B
Anticancer Res; 2003; 23(2B):1467-71. PubMed ID: 12820411
[TBL] [Abstract][Full Text] [Related]
6. MHC class II expression by follicular keratinocytes in canine demodicosis--an immunohistochemical study.
Huisinga M; Failing K; Reinacher M
Vet Immunol Immunopathol; 2007 Aug; 118(3-4):210-20. PubMed ID: 17604845
[TBL] [Abstract][Full Text] [Related]
7. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
8. Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells.
Housseau F; Bright RK; Simonis T; Nishimura MI; Topalian SL
J Immunol; 1999 Dec; 163(11):6330-7. PubMed ID: 10570328
[TBL] [Abstract][Full Text] [Related]
9. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
[TBL] [Abstract][Full Text] [Related]
10. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
11. Quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes.
Meunier L; Vian L; Lagoueyte C; Lavabre-Bertrand T; Duperray C; Meynadier J; Cano JP
Cytometry; 1996 Dec; 26(4):260-4. PubMed ID: 8979024
[TBL] [Abstract][Full Text] [Related]
12. Cytosolic aminopeptidases influence MHC class I-mediated antigen presentation in an allele-dependent manner.
Kim E; Kwak H; Ahn K
J Immunol; 2009 Dec; 183(11):7379-87. PubMed ID: 19917696
[TBL] [Abstract][Full Text] [Related]
13. Methods in laboratory investigation. Immunoelectron microscopic methods for demonstration of antigens on normal human melanocytes and other epidermal cells.
van Duinen SG; Mauw BJ; de Graaff-Reitsma CB; Ruiter DJ
Lab Invest; 1984 Jun; 50(6):733-41. PubMed ID: 6427521
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility class II expression in the normal canine cornea and in canine chronic superficial keratitis.
Williams DL
Vet Ophthalmol; 2005; 8(6):395-400. PubMed ID: 16359362
[TBL] [Abstract][Full Text] [Related]
16. The human hair follicle immune system: cellular composition and immune privilege.
Christoph T; Müller-Röver S; Audring H; Tobin DJ; Hermes B; Cotsarelis G; Rückert R; Paus R
Br J Dermatol; 2000 May; 142(5):862-73. PubMed ID: 10809841
[TBL] [Abstract][Full Text] [Related]
17. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
[TBL] [Abstract][Full Text] [Related]
19. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]